In vivo biocompatibility of dextran-based hydrogels

Journal of Biomedical Materials Research

Volumn 50, Issue 3, 2000, Pages 397-404

  Cadee J A ^a   Van Luyn, M J A ^b   Brouwer, L A ^b   Plantinga, J A ^b   Van Wachem, P B ^b   De Groot, C J ^c   Den Otter, W ^c   Hennink, W E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Faculty of Veterinary Medicine   (Netherlands)

Author keywords

Biocompatibility; Biodegradable; Dextran; Hydrogel

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOCOMPATIBILITY; BIODEGRADATION; CELLS; CHEMICAL BONDS; HYDROGELS; HYDROLYSIS; POLYSACCHARIDES;

DEXTRAN;

BIOMATERIALS;

BIOMATERIAL; DEXTRAN; POLYMACON; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CELL INFILTRATION; CONTROLLED STUDY; HYDROGEL; HYDROLYSIS; IMPLANTATION; MALE; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; RAT; TISSUE REACTION; WATER CONTENT;

ANIMALS; BIOCOMPATIBLE MATERIALS; DEXTRANS; FOREIGN-BODY REACTION; HYDROGELS; RATS;

EID: 0034072747     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(20000605)50:3<397::AID-JBM14>3.0.CO;2-A     Document Type: Article

References (20)

1. Park H, Park K. Issues of implantable drug delivery systems. Pharm Res 1996;13:1770-1776.
2. Van Dijk-Wolthuis WNE, Hoogeboom JAM, van Steenbergen MJ, Tsang SKY, Hennink WE. Degradation and release behavior of dextran-based hydrogels. Macromolecules 1997;30:4639-4645.
3. Hennink WE, Franssen O, van Dijk-Wolthuis WNE, Talsma H. Dextran hydrogels for the controlled release of proteins. J Controlled Release 1997;48:107-114.
4. Van Dijk-Wolthuis WNE, Franssen O, Talsma H, van Steenbergen MJ, Kettenes-van den Bosch JJ, Hennink WE. Synthesis, characterization and polymerization of glycidyl methacrylate-derivatized dextran. Macromolecules 1995;28:6317-6322.
5. Van Dijk-Wolthuis WNE, Kettenes-van den Bosch JJ, van der Kerk-van Hoof A, Hennink WE. Reaction of dextran with glycidyl methacrylate: An unexpected transesterification. Macromolecules 1997;30:3411-3413.
6. Van Dijk-Wolthuis WNE, Tsang SKY, Kettenes-van den Bosch JJ, Hennink WE. A new class of polymerizable dextrans with hydrolyzable groups: Hydroxyethyl methacrylated dextran with and without oligolactate spacer. Polymer 1997;38:6235-6242.
7. Van Dijk-Wolthuis WNE, van Steenbergen MJ, Underberg WJM, Hennink WE. Degradation kinetics of methacrylated dextrans in aqueous solution. J Pharm Sci 1997;86:413-417.
8. Bancroft JD, Stevens A. Theory and practice of histological techniques. Edinburg: Churchill Livingstone; 1988. p 187-189.
9. Andersen JM, Miller KM. Biomaterial biocompatibility and the macrophage. Biomaterials 1984;5:5-10.
10. Andersen JM. In vivo biocompatibility of implantable delivery systems and biomaterials. Eur J Pharm Biopharm 1994;40:1-8.
11. Andersen JM, Niven H, Pelagalli J, Olanoff LS, Jones RD. The role of the fibrous capsule in the function of implanted drugpolymer sustained release systems. J Biomed Mater Res 1981; 15:889-902.
12. Andersen JM, Langone JJ. Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems. J Controlled Release 1999; 57:107-113.
13. Robbins SL, Cotran RS, Kumad V. Pathologic basis of disease. Philadelphia: WB Saunders Co.; 1984. p 40-85.
14. Van Wachem PB, van Luyn MJA, Koerten HK, Olde Damink LHH, Ten Hoopen H, Feijen J, Nieuwenhuis P. In vivo degradation of processed dermal sheep collagen evaluated with transmission electron microscopy. Biomaterials 1991;12:215-223.
15. Van Wachem PB, van Luyn MJA, Olde Damink LHH, Dijkstra PJ, Feijen J, Nieuwenhuis P. Biocompatibility and tissue-regenerating capacity of crosslinked dermal sheep collagen. J Biomed Mater Res 1994;28:353-363.
16. Draye J-P, Delaey B, van de Voorde A, van den Bulcke A, de Reu B, Schacht E. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 1998;19:1677-1687.
17. Hooper KA, Macon ND, Kohn J. Comparative histological evaluation of new tyrosine-derived polymers and poly (L-lactic acid) as a function of polymer degradation. J Biomed Mater Res 1998;41:443-454.
18. Holder WD Jr, Gruber HE, Moore AL, Culberson CR, Anderson W, Burg KJL, Mooney DJ. Cellular ingrowth and thickness changes in poly-L-lactide and polyglycolide matrices implanted subcutaneously in the rat. J Biomed Mater Res 1998; 41:412-421.
19. Lescure F, Gurny R, Doelker E, Anderson JM. Long-term histopathological study of new polypeptidic biomaterials. Biomaterials 1992;13:1009-1011.
20. Rihova B. Biocompatibility of biomaterials: Hemocompatibility, immunocompatibility and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv Drug Del Rev 1996;21:157-176.